Statement of Financial Position Statement (USD $) In Thousands	Jun. 30, 2011	Dec. 31, 2010
Cash and Cash Equivalents, at Carrying Value	$ 24,561	$ 133,880
Accounts Receivable, Net	160,208	154,726
Inventory, Net	42,508	33,979
Prepaid Expense and Other Assets	27,414	26,735
TOTAL CURRENT ASSETS	254,691	349,320
Property, Plant and Equipment, Net	105,126	104,223
Intangible Assets, Net (Excluding Goodwill)	8,202	8,660
Goodwill	154,217	154,217
Deferred Tax Assets, Net, Noncurrent	6,802	0
Other Assets, Noncurrent	23,195	19,622
TOTAL ASSETS	552,233	636,042
Accounts Payable, Current	61,331	44,710
Employee-related Liabilities, Current	28,087	28,621
Sales and Excise Tax Payable, Current	9,116	7,796
Deferred Revenue, Current	22,830	20,181
Taxes Payable, Current	12,234	21,004
Convertible Debt, Current	89,747	147,543
Other Accrued Liabilities, Current	12,753	9,498
TOTAL CURRENT LIABILITIES	236,098	279,353
Deferred Compensation Liability, Classified, Noncurrent	24,001	21,241
Deferred Tax Liabilities, Noncurrent	0	2,198
Other Liabilities, Noncurrent	37,749	32,046
Commitments and Contingencies	0	0
Temporary Equity, Redemption Value	2,183	8,864
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	1,397	1,397
Additional Paid in Capital, Common Stock	0	0
Retained Earnings (Accumulated Deficit)	459,634	536,991
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,055)	(6,207)
Treasury shares (at cost), xxx at 2011 and 4,218,726 at 2010	(205,913)	(242,690)
Total Core Laboratories N.V. shareholders' equity	249,063	289,491
Stockholders' Equity Attributable to Noncontrolling Interest	3,139	2,849
TOTAL EQUITY	252,202	292,340
TOTAL LIABILITIES AND EQUITY	$ 552,233	$ 636,042